Big Question?If the Pg BLA plan is approved by the FDA in mid-September will this be enough to trigger a partnership deal on Ryplazim as raised by PL during the last conference call? No doubt in my mind, that FDA approval of the PLAN will mean that approval of Ryplazim is guaranteed within 2-6 months following submission of the revised BLA. So will Big Pharma jump in September and start work on all the acute deficiency and SC applications of Pg or wait until formal approval of the BLA by the FDA sometime next year?